Impact Nerium Oleander on Immune Function
Covid19 Positive Patient, Covid19 Close Contact, Immune Function
About this trial
This is an interventional treatment trial for Covid19 Positive Patient focused on measuring Covid19, Nerium oleander, Clinical symptoms, Mortality, Immune Function
Eligibility Criteria
Inclusion Criteria:
- Age 18
- COVID 19 positive or close contact of COVID 19 positive
- No use of cardiac glycosides or other antiarrhythmic medications
Exclusion Criteria:
- No use of cardiac glycosides or other antiarrhythmic medications
- No allergy to coconut oil
Sites / Locations
- KDunn and Associates, PA, dba Healthquilt
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
No Intervention
Experimental
No Intervention
COVID19 Positive: Intervention Group (Receive extract)
COVID19 Positive: Comparison Group (Do NOT receive extract)
COVID19 Exposed: Intervention Group (Receive extract)
COVID19 Exposed: Comparison Group (Do NOT receive extract)
These are patients that are COVID19 positive who elect to try the extract.
These are patients that are COVID19 positive who do NOT elect to try the extract
These are patients that are COVID19 negative at the start, live with a COVID19 positive patient and who elect to try the extract.
These are patients that are COVID19 negative at the start, live with a COVID19 positive patient and who elect to NOT try the extract.